 | • レポートコード：GIR201113870 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の世界市場を調査対象にし、循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（セルサーチ、その他）、用途別分析（乳がん診断及び治療、前立腺がん診断及び治療、結腸直腸がん診断及び治療、肺がん診断及び治療、その他がん診断及び治療）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Janssen、Celsee、ApoCell、Qiagen、CytoTrack、Advanced Cell Diagnostics、Gilupi、Clearbridge Biomedics、Biofluidica、Fluxion、Fluidigm、IVDiagnostics、Cynvenio、ScreenCell、Ikonisys、BioView、On-chip、Miltenyi Biotec、AdnaGen、YZY Bio、Silicon Biosystems ・企業別売上、市場シェア ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の地域別市場分析 ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の種類別市場規模2015-2020：セルサーチ、その他 ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の用途別市場規模2015-2020：乳がん診断及び治療、前立腺がん診断及び治療、結腸直腸がん診断及び治療、肺がん診断及び治療、その他がん診断及び治療 ・循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 20.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 20860 million by 2025, from USD 9900 million in 2019.
Market segmentation
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market has been segmented into:
CellSearch
Others
By Application, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) has been segmented into:
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market.
The report offers in-depth assessment of the growth and other aspects of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Analysis
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) sales, revenue and market share for each player covered in this report.
The major players covered in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are:
Janssen
Celsee
ApoCell
Qiagen
CytoTrack
Advanced Cell Diagnostics
Gilupi
Clearbridge Biomedics
Biofluidica
Fluxion
Fluidigm
IVDiagnostics
Cynvenio
ScreenCell
Ikonisys
BioView
On-chip
Miltenyi Biotec
AdnaGen
YZY Bio
Silicon Biosystems
Among other players domestic and global, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
1.2 Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Type
1.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type in 2019
1.2.3 CellSearch
1.2.4 Others
1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Application
1.3.1 Overview: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Other Cancers Diagnosis and Treatment
1.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Regions
1.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Janssen
2.1.1 Janssen Details
2.1.2 Janssen Major Business
2.1.3 Janssen SWOT Analysis
2.1.4 Janssen Product and Services
2.1.5 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celsee
2.2.1 Celsee Details
2.2.2 Celsee Major Business
2.2.3 Celsee SWOT Analysis
2.2.4 Celsee Product and Services
2.2.5 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.3 ApoCell
2.3.1 ApoCell Details
2.3.2 ApoCell Major Business
2.3.3 ApoCell SWOT Analysis
2.3.4 ApoCell Product and Services
2.3.5 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen SWOT Analysis
2.4.4 Qiagen Product and Services
2.4.5 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.5 CytoTrack
2.5.1 CytoTrack Details
2.5.2 CytoTrack Major Business
2.5.3 CytoTrack SWOT Analysis
2.5.4 CytoTrack Product and Services
2.5.5 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Advanced Cell Diagnostics
2.6.1 Advanced Cell Diagnostics Details
2.6.2 Advanced Cell Diagnostics Major Business
2.6.3 Advanced Cell Diagnostics Product and Services
2.6.4 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gilupi
2.7.1 Gilupi Details
2.7.2 Gilupi Major Business
2.7.3 Gilupi Product and Services
2.7.4 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Clearbridge Biomedics
2.8.1 Clearbridge Biomedics Details
2.8.2 Clearbridge Biomedics Major Business
2.8.3 Clearbridge Biomedics Product and Services
2.8.4 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biofluidica
2.9.1 Biofluidica Details
2.9.2 Biofluidica Major Business
2.9.3 Biofluidica Product and Services
2.9.4 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fluxion
2.10.1 Fluxion Details
2.10.2 Fluxion Major Business
2.10.3 Fluxion Product and Services
2.10.4 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Fluidigm
2.11.1 Fluidigm Details
2.11.2 Fluidigm Major Business
2.11.3 Fluidigm Product and Services
2.11.4 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.12 IVDiagnostics
2.12.1 IVDiagnostics Details
2.12.2 IVDiagnostics Major Business
2.12.3 IVDiagnostics Product and Services
2.12.4 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Cynvenio
2.13.1 Cynvenio Details
2.13.2 Cynvenio Major Business
2.13.3 Cynvenio Product and Services
2.13.4 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.14 ScreenCell
2.14.1 ScreenCell Details
2.14.2 ScreenCell Major Business
2.14.3 ScreenCell Product and Services
2.14.4 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ikonisys
2.15.1 Ikonisys Details
2.15.2 Ikonisys Major Business
2.15.3 Ikonisys Product and Services
2.15.4 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.16 BioView
2.16.1 BioView Details
2.16.2 BioView Major Business
2.16.3 BioView Product and Services
2.16.4 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.17 On-chip
2.17.1 On-chip Details
2.17.2 On-chip Major Business
2.17.3 On-chip Product and Services
2.17.4 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.18 Miltenyi Biotec
2.18.1 Miltenyi Biotec Details
2.18.2 Miltenyi Biotec Major Business
2.18.3 Miltenyi Biotec Product and Services
2.18.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.19 AdnaGen
2.19.1 AdnaGen Details
2.19.2 AdnaGen Major Business
2.19.3 AdnaGen Product and Services
2.19.4 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.20 YZY Bio
2.20.1 YZY Bio Details
2.20.2 YZY Bio Major Business
2.20.3 YZY Bio Product and Services
2.20.4 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.21 Silicon Biosystems
2.21.1 Silicon Biosystems Details
2.21.2 Silicon Biosystems Major Business
2.21.3 Silicon Biosystems Product and Services
2.21.4 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share
3.2.2 Top 10 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
4.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
4.5 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
5 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries
5.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
5.2 USA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
5.3 Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
5.4 Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
6 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries
6.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
6.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
6.3 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
6.4 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
6.5 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
6.6 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
7.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
7.3 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
7.4 Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
7.5 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
8 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries
8.1 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
8.2 Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
8.3 Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
9.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
9.3 UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
9.4 Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
9.5 South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2015-2020)
10.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Type (2019-2024)
10.3 CellSearch Revenue Growth Rate (2015-2025)
10.4 Others Revenue Growth Rate (2015-2025)
11 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment by Application
11.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2015-2020)
11.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Application (2019-2024)
11.3 Breast Cancer Diagnosis and Treatment Revenue Growth (2015-2020)
11.4 Prostate Cancer Diagnosis and Treatment Revenue Growth (2015-2020)
11.5 Colorectal Cancer Diagnosis and Treatment Revenue Growth (2015-2020)
11.6 Lung Cancer Diagnosis and Treatment Revenue Growth (2015-2020)
11.7 Other Cancers Diagnosis and Treatment Revenue Growth (2015-2020)
12 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2021-2025)
12.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2021-2025)
12.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Regions (2021-2025)
12.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
12.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
12.6 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Janssen Corporate Information, Location and Competitors
Table 7. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 8. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 9. Janssen SWOT Analysis
Table 10. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 11. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Celsee Corporate Information, Location and Competitors
Table 13. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 14. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2018-2019)
Table 15. Celsee SWOT Analysis
Table 16. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 17. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. ApoCell Corporate Information, Location and Competitors
Table 19. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 20. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 21. ApoCell SWOT Analysis
Table 22. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 23. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Qiagen Corporate Information, Location and Competitors
Table 25. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 26. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 27. Qiagen SWOT Analysis
Table 28. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 29. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. CytoTrack Corporate Information, Location and Competitors
Table 31. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 32. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 33. CytoTrack SWOT Analysis
Table 34. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 35. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Advanced Cell Diagnostics Corporate Information, Location and Competitors
Table 37. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 38. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 39. Advanced Cell Diagnostics SWOT Analysis
Table 40. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 41. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Gilupi Corporate Information, Location and Competitors
Table 43. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 44. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 45. Gilupi SWOT Analysis
Table 46. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 47. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Clearbridge Biomedics Corporate Information, Location and Competitors
Table 49. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 50. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 51. Clearbridge Biomedics SWOT Analysis
Table 52. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 53. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Biofluidica Corporate Information, Location and Competitors
Table 55. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 56. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 57. Biofluidica SWOT Analysis
Table 58. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 59. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Fluxion Corporate Information, Location and Competitors
Table 61. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 62. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 63. Fluxion SWOT Analysis
Table 64. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 65. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Fluidigm Corporate Information, Location and Competitors
Table 67. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 68. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 69. Fluidigm SWOT Analysis
Table 70. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 71. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. IVDiagnostics Corporate Information, Location and Competitors
Table 73. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 74. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 75. IVDiagnostics SWOT Analysis
Table 76. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 77. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Cynvenio Corporate Information, Location and Competitors
Table 79. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 80. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 81. Cynvenio SWOT Analysis
Table 82. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 83. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. ScreenCell Corporate Information, Location and Competitors
Table 85. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 86. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 87. ScreenCell SWOT Analysis
Table 88. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 89. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Ikonisys Corporate Information, Location and Competitors
Table 91. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 92. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 93. Ikonisys SWOT Analysis
Table 94. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 95. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. BioView Corporate Information, Location and Competitors
Table 97. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 98. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 99. BioView SWOT Analysis
Table 100. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 101. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. On-chip Corporate Information, Location and Competitors
Table 103. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 104. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 105. On-chip SWOT Analysis
Table 106. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 107. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Application
Table 109. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 110. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 111. Miltenyi Biotec SWOT Analysis
Table 112. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 113. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. AdnaGen Corporate Information, Location and Competitors
Table 115. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 116. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 117. AdnaGen SWOT Analysis
Table 118. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 119. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. YZY Bio Corporate Information, Location and Competitors
Table 121. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 122. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 123. YZY Bio SWOT Analysis
Table 124. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 125. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Silicon Biosystems Corporate Information, Location and Competitors
Table 127. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Business
Table 128. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Total Revenue (USD Million) (2017-2018)
Table 129. Silicon Biosystems SWOT Analysis
Table 130. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product and Solutions
Table 131. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Players (2015-2020)
Table 133. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Players (2015-2020)
Table 134. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Regions (2015-2020)
Table 135. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Regions (2015-2020)
Table 136. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
Table 137. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Table 138. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Countries (2015-2020)
Table 139. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Countries (2015-2020)
Table 140. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2015-2020)
Table 141. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Table 142. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Countries (2015-2020)
Table 143. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Table 144. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Type (2015-2020)
Table 145. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Type (2015-2020)
Table 146. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Forecast by Type (2021-2025)
Table 147. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Application (2015-2020)
Table 148. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Application (2015-2020)
Table 149. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Forecast by Application (2021-2025)
Table 150. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Picture
Figure 2. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type in 2019
Figure 3. CellSearch Picture
Figure 4. Others Picture
Figure 5. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application in 2019
Figure 6. Breast Cancer Diagnosis and Treatment Picture
Figure 7. Prostate Cancer Diagnosis and Treatment Picture
Figure 8. Colorectal Cancer Diagnosis and Treatment Picture
Figure 9. Lung Cancer Diagnosis and Treatment Picture
Figure 10. Other Cancers Diagnosis and Treatment Picture
Figure 11. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share in 2019
Figure 20. Global Top 10 Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Regions (2015-2020)
Figure 24. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Regions in 2018
Figure 25. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 26. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 28. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 30. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Figure 31. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries in 2019
Figure 32. USA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 33. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 35. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries in 2019
Figure 37. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 38. UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 39. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 40. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 41. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries in 2019
Figure 44. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 45. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 46. Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 47. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 49. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Figure 50. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries in 2019
Figure 51. Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 56. UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2015-2020)
Figure 59. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Type (2015-2020)
Figure 60. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Type in 2019
Figure 61. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Type (2021-2025)
Figure 62. Global CellSearch Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Application (2015-2020)
Figure 65. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Application in 2019
Figure 66. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Application (2021-2025)
Figure 67. Global Breast Cancer Diagnosis and Treatment Revenue Growth Rate (2015-2020)
Figure 68. Global Prostate Cancer Diagnosis and Treatment Revenue Growth Rate (2015-2020)
Figure 69. Global Colorectal Cancer Diagnosis and Treatment Revenue Growth Rate (2015-2020)
Figure 70. Global Lung Cancer Diagnosis and Treatment Revenue Growth Rate (2015-2020)
Figure 71. Global Other Cancers Diagnosis and Treatment Revenue Growth Rate (2015-2020)
Figure 72. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
Figure 76. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
Figure 78. South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
幹細胞の世界市場 2020年 Market Overview The Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 同種幹細胞の世界市場 2020年 Market Overview The Allogeneic Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 間葉系幹細胞の世界市場 2020年 Market Overview The Mesenchymal Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 幹細胞凍結保存装置の世界市場 2020年 Market Overview The Stem Cells Cryopreservation Equipments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…
- 液体生検用循環バイオマーカーの世界市場 2020年 Market Overview The global Circulating Biomarker for Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circu…